Combination Chemotherapy in Treating Patients With Non-Hodgkin’s Lymphoma or Acute Lymphocytic Leukemia
Study Information
Alliance Study ID: CALGB-9251
NCT Study ID (ClinicalTrials.gov): NCT00002494
Alliance Committee: Lymphoma
Disease or Cancer Type: Leukemia & Myelodysplastic Syndromes (MDS), Lymphoma
Alliance Study Chair: Edward Lee, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and alternating regimens of chemotherapy in treating patients who have non-Hodgkin’s lymphoma or acute lymphocytic leukemia.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information